Kyle Wilson

Kyle Wilson is a Partner at BroadOak Capital Partners, a privately held investment bank focused on the life sciences industry since March 2011. Additionally, Kyle serves on the Advisory Board of Slone Partners and was a Board Member at Techcyte until April 2023. Previously, Kyle held the position of Business Advisory Member at Cenetron Diagnostics from March 2012 to July 2019, and worked as a Principal at Canaccord Genuity from February 2004 to March 2011. Early career roles include Vice President at RBC Capital Markets and Associate at Morgan Keegan. Kyle holds an MBA and a JD from the University of Oklahoma, as well as a BBA in Finance from the same institution.